These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6206714)

  • 1. Use of a modified procedure for treating small amounts of red blood cells with 2-aminoethylisothiouronium bromide.
    Ellisor SS; O'Day T; Reid ME; Arndt L; Sugasawara E
    Am J Clin Pathol; 1984 Oct; 82(4):439-41. PubMed ID: 6206714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of Kell blood group antigens by 2-aminoethylisothiouronium bromide.
    Advani H; Zamor J; Judd WJ; Johnson CL; Marsh WL
    Br J Haematol; 1982 May; 51(1):107-15. PubMed ID: 7073987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Another example of mimicking anti-Kpb in a Kp(a+b-) patient.
    Puig N; Carbonell F; Marty ML
    Vox Sang; 1986; 51(1):57-9. PubMed ID: 3739324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "New" autoantibody specificity in autoimmune hemolytic anemia defined with red cells treated with 2-aminoethylisothiouronium bromide and a dithiothreitol-papain solution.
    Marsh WL; DiNapoli J; Oyen R; Pacanowski L; Kessler LA
    Transfusion; 1985; 25(4):364-7. PubMed ID: 4024234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmunity and the Kell blood groups: auto-anti-Kpb in a Kp(a+b-) patient.
    Manny N; Levene C; Sela R; Johnson CL; Mueller KA; Marsh WL
    Vox Sang; 1983; 45(3):252-6. PubMed ID: 6624011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence of red cell alloantibodies underlying panreactive warm autoantibodies.
    Maley M; Bruce DG; Babb RG; Wells AW; Williams M
    Immunohematology; 2005; 21(3):122-5. PubMed ID: 16178670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and specificity of red cell antibodies in thalassemia patients in Albania.
    Seferi I; Xhetani M; Face M; Burazeri G; Nastas E; Vyshka G
    Int J Lab Hematol; 2015 Aug; 37(4):569-74. PubMed ID: 25865362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohematologic study and transfusion approach to patients with public antibodies].
    Solves P; de la Rubia J; Arriaga F; Cervera J; Arnao M; Carpio N; Marty ML
    Sangre (Barc); 1997 Feb; 42(1):25-9. PubMed ID: 9229799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired loss of red cell Kell antigens.
    Vengelen-Tyler V; Gonzalez B; Garratty G; Kruppe C; Johnson CL; Mueller KA; Marsh WL
    Br J Haematol; 1987 Feb; 65(2):231-4. PubMed ID: 3828231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Kmod blood group phenotype in a healthy individual.
    Winkler MM; Beattie KM; Cisco SL; Sigmund KE; Johnson CL; Rabin BI; Marsh WL
    Transfusion; 1989 Sep; 29(7):642-5. PubMed ID: 2773032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new low-incidence antigen in the Kell blood group system: VLAN (KEL25).
    Jongerius JM; Daniels GL; Overbeeke MA; Petty AC; Reid M; Oyen R; Rijksen H; van Leeuwen EF
    Vox Sang; 1996; 71(1):43-7. PubMed ID: 8837356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of Kell blood group antigens by 2-aminoethylisothiouronium bromide.
    Moulds JJ; Moulds MK
    Transfusion; 1983; 23(3):274-5. PubMed ID: 6679393
    [No Abstract]   [Full Text] [Related]  

  • 13. Auto anti-Kpb associated with weakened antigenicity in the Kell blood group system: a second example.
    Beck ML; Marsh WL; Pierce SR; DiNapoli J; Oyen R; Nichols ME
    Transfusion; 1979; 19(2):197-202. PubMed ID: 86215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red cell alloantibodies in thalassemia major. Results of an Italian cooperative study.
    Sirchia G; Zanella A; Parravicini A; Morelati F; Rebulla P; Masera G
    Transfusion; 1985; 25(2):110-2. PubMed ID: 3920790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AET-treated platelets: their usefulness for platelet antibody detection and an examination of their altered sensitivity to immune lysis.
    Cimo PL; Gerber SA
    Blood; 1979 Nov; 54(5):1101-8. PubMed ID: 574032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
    Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
    Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosetting of human T lymphocytes with goat red blood cells: effect of treatment with 2-aminoethylisothiouronium bromide (AET) and comparison with AET treated sheep red blood cells.
    Indiveri F; Pellegrino MA; Molinaro GA; Quaranta V; Ferrone S
    J Immunol Methods; 1979; 30(4):317-28. PubMed ID: 315972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune hemolytic anemia and the Kell blood groups.
    Marsh WL; Oyen R; Alicea E; Linter M; Horton S
    Am J Hematol; 1979; 7(2):155-62. PubMed ID: 539592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of 136 patient's antibodies to human red blood cells in Dr. Max Peralta J Hospital Blood Bank 2004-February 2009.
    Cerdas-Quesada C
    Transfus Apher Sci; 2010 Apr; 42(2):105-8. PubMed ID: 20100667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red cell autoantibodies characterized by competitive inhibition of iodine 125 Rh alloantibody binding and by immunoprecipitation of membrane proteins.
    Pierce SW; Victoria EJ; Masouredis SP
    J Lab Clin Med; 1990 Dec; 116(6):805-13. PubMed ID: 1701002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.